These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 8549350

  • 1. NM441: penetration into gynaecological tissues and in vitro activity against clinical isolates from obstetric and gynaecological patients.
    Mikamo H, Kawazoe K, Izumi K, Ito K, Tamaya T.
    Drugs; 1995; 49 Suppl 2():326-30. PubMed ID: 8549350
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. In vivo antibacterial activity of a prodrug of NM394, a thiazetoquinoline carboxylic acid derivative.
    Ozaki M, Tomii Y, Matsuda M, Segawa J, Kitano M, Kise M, Nishino T.
    Chemotherapy; 1998; 44(1):21-30. PubMed ID: 9444405
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics of prulifloxacin. 2nd communication: pharmacokinetics and effect on hepatic drug-metabolizing enzyme activities after repeated administration and transfer into fetus and milk after a single administration in rats.
    Okuyama Y, Momota K, Morino A.
    Arzneimittelforschung; 1997 Mar; 47(3):285-92. PubMed ID: 9105547
    [Abstract] [Full Text] [Related]

  • 5. Penetration of NM441, a new quinolone, into human bile and gallbladder tissue.
    Tanimura H, Ishimoto K, Murakami K, Uchiyama K, Iwakura S.
    Drugs; 1995 Mar; 49 Suppl 2():337-40. PubMed ID: 8549354
    [No Abstract] [Full Text] [Related]

  • 6. Therapeutic effect of the quinolone prodrug prulifloxacin against experimental urinary tract infections in mice.
    Tomii Y, Ozaki M, Matsuda M, Honmura T, Nishimura I, Yamaguchi R, Adachi T, Okawa Y, Nishino T.
    Arzneimittelforschung; 1996 Dec; 46(12):1169-73. PubMed ID: 9006794
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. In vivo evaluation of NM441, a new thiazeto-quinoline derivative.
    Ozaki M, Matsuda M, Tomii Y, Kimura K, Segawa J, Kitano M, Kise M, Shibata K, Otsuki M, Nishino T.
    Antimicrob Agents Chemother; 1991 Dec; 35(12):2496-9. PubMed ID: 1667252
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. In vitro antibacterial activities of AF 3013, the active metabolite of prulifloxacin, against nosocomial and community Italian isolates.
    Montanari MP, Mingoia M, Varaldo PE.
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3616-22. PubMed ID: 11709353
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics of prulifloxacin. 3rd communication: metabolism in rats, dogs and monkeys.
    Okuyama Y, Morino A.
    Arzneimittelforschung; 1997 Mar; 47(3):293-8. PubMed ID: 9105548
    [Abstract] [Full Text] [Related]

  • 16. [Clinical study of prulifloxacin on infectious enteritis. Japan Research Committee of Prulifloxacin, Research Group on Infectious Enteritis].
    Tomizawa I, Takizawa Y, Nitta Y, Tsunoda T, Fukuda H, Yamaguchi T, Masuda G, Negishi M, Ajisawa A, Murata M, Ohnishi K, Irimajiri S, Obana M, Sajima Y, Sagara H, Kato H, Hosoda S, Banba T, Sasaki M, Yoshikawa K, Nakagawa M, Ohkubo H, Kim Y, Akao M, Fukuyama M.
    Kansenshogaku Zasshi; 1996 Jul; 70(7):727-45. PubMed ID: 8797308
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. ESGAB breakpoint determination: temafloxacin.
    Phillips I, Acar J, Baquero F, Bergan T, Forsgren A, Wiedemann B.
    Eur J Clin Microbiol Infect Dis; 1991 Nov; 10(11):991-2. PubMed ID: 1665417
    [No Abstract] [Full Text] [Related]

  • 19. In-vitro activity of OPC-17116 against more than 6000 consecutive clinical isolates: a multicentre international study.
    Marco F, Jones RN, Hoban DJ, Pignatari AC, Yamane N, Frei R.
    J Antimicrob Chemother; 1994 Mar; 33(3):647-54. PubMed ID: 8040130
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.